Villalobos Anabella
SEC insider (Form 3/4/5 filer). CIK 0001952966. Director at Coya Therapeutics, Inc. (COYA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in HOUSTON, TX.
Companies Villalobos Anabella has filed insider reports for
- Coya Therapeutics, Inc. (COYA): Director
Villalobos Anabella
CIK: 0001952966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COYA
Coya Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 2, 2026COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10K shares- - Feb 25, 2025COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares- - Jan 1, 2025COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares-
1-3 of 3 transactions